ACGLN vs DGX · P/E 3.6, $15.30B cap vs P/E 22, rev $5.94B
Arch Capital Group Ltd (ACGLN) versus Quest Diagnostics Incorporated (DGX) — a side-by-side from cached financials, not a winner call.
Arch Capital Group Ltd (ACGLN) is a insurance - diversified company listed on US.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
ACGLN does not have a complete income-statement cache yet.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
ACGLN currently screens at market cap $15.30B and trailing P/E 3.6. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Not investment advice. Open the ACGLN and DGX stock pages for the full models.
Not investment advice.